|
HY-100027A-10mg
|
MedChemexpress LLC
|
Ro 41-1049 (hydrochloride) [CAS 127917-66-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100027A-100mg
|
MedChemexpress LLC
|
Ro 41-1049 (hydrochloride) [CAS 127917-66-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100027A-5mg
|
MedChemexpress LLC
|
Ro 41-1049 (hydrochloride) [CAS 127917-66-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100027A-50mg
|
MedChemexpress LLC
|
Ro 41-1049 (hydrochloride) [CAS 127917-66-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100029-10mg
|
MedChemexpress LLC
|
Bay 41-4109 [CAS 298708-81-3]
|
|
COVID-19-anti-virus
|
|
|
HY-100029-100mg
|
MedChemexpress LLC
|
Bay 41-4109 [CAS 298708-81-3]
|
|
COVID-19-anti-virus
|
|
|
HY-100029-5mg
|
MedChemexpress LLC
|
Bay 41-4109 [CAS 298708-81-3]
|
|
COVID-19-anti-virus
|
|
|
HY-100029-50mg
|
MedChemexpress LLC
|
Bay 41-4109 [CAS 298708-81-3]
|
|
COVID-19-anti-virus
|
|
|
HY-100029A-1mg
|
MedChemexpress LLC
|
Bay 41-4109 (racemate) [CAS 298708-79-9]
|
|
COVID-19-anti-virus
|
|
|
HY-100029A-10mg
|
MedChemexpress LLC
|
Bay 41-4109 (racemate) [CAS 298708-79-9]
|
|
COVID-19-anti-virus
|
|
|
HY-100029A-100mg
|
MedChemexpress LLC
|
Bay 41-4109 (racemate) [CAS 298708-79-9]
|
|
COVID-19-anti-virus
|
|
|
HY-100029A-5mg
|
MedChemexpress LLC
|
Bay 41-4109 (racemate) [CAS 298708-79-9]
|
|
COVID-19-anti-virus
|
|
|
HY-100029A-50mg
|
MedChemexpress LLC
|
Bay 41-4109 (racemate) [CAS 298708-79-9]
|
|
COVID-19-anti-virus
|
|
|
HY-100064-10mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100064-25mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100064-5mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100064-50mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-10007-10mg
|
MedChemexpress LLC
|
NPS-2143 [CAS 284035-33-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10007-100mg
|
MedChemexpress LLC
|
NPS-2143 [CAS 284035-33-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10007-5mg
|
MedChemexpress LLC
|
NPS-2143 [CAS 284035-33-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10007-50mg
|
MedChemexpress LLC
|
NPS-2143 [CAS 284035-33-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-100083-1g
|
MedChemexpress LLC
|
Dolutegravir intermediate-1 [CAS 1335210-23-5]
|
|
|
|
|
HY-100083-100mg
|
MedChemexpress LLC
|
Dolutegravir intermediate-1 [CAS 1335210-23-5]
|
|
|
|
|
HY-100083-500mg
|
MedChemexpress LLC
|
Dolutegravir intermediate-1 [CAS 1335210-23-5]
|
|
|
|
|
HY-100128-10mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
